Tailoring treatments according to the distinct features of the breast tumor microenvironment and its interactions with different molecular subtypes of breast cancer may facilitate the development of personalized medicine approaches
Busada JT, Peterson KN, Khadka S, Xu X, Oakley RH, Cook DN, et al
Recalls & Warnings January 17, 2018 Joint and Pain Relief Product Contains Undeclared Drug On January 17, 2018 Health Canada warned consumers that Linsen Double Caulis Plus, a supplement for joint pain, was found to contain the undeclared drug dexamethasone
10.1016/j.apsb.2019.03.001 Acta Pharm
Compound 9 fit perfectly within the COX-2 active site and exhibited the highest COX-2 SI of all the tested compounds
10.1016/j.heliyon.2023.e21950 140 WangA.GuanB.YuL.LiuQ.HouY.LiZ.et al (2024a)